The joy of your baby’s birth could be shared with someone who has a life-threatening illness.
After a baby is born, the umbilical cord and placenta are no longer needed and are usually discarded. However, the blood remaining in the umbilical cord and placenta is rich with blood-forming cells. (These cells are not embryonic stem cells.) By collecting and freezing this blood, the healthy blood-forming cells can be stored and may later be used by a patient who needs them.
Patients with leukemia, lymphoma, or certain inherited metabolic or immune system disorders have diseased blood-forming cells. For some patients, an umbilical cord blood or bone marrow transplant (also called a BMT) may be their best treatment option.
Learn how umbilical cord blood may be able to help a patient in need.
HRSA has published a Request for Information (RFI) for the National Cord Blood Inventory (NCBI) . The purpose is to obtain feedback from the blood stem cell transplantation community that may help guide HRSA future funding decisions for the NCBI program. Please share this opportunity with your colleagues.